VIVSVIVSNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P31
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-8.60%
2024-38.12%
2023167.62%
2022201.00%
2021-79.13%
2020-64.18%
2019-17.84%
2018-8.13%
20178.54%
201639.37%